OMCL logo

Omnicell, Inc. Stock Price

NasdaqGS:OMCL Community·US$1.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

OMCL Share Price Performance

US$36.51
-10.08 (-21.64%)
US$47.33
Fair Value
US$36.51
-10.08 (-21.64%)
22.9% undervalued intrinsic discount
US$47.33
Fair Value
Price US$36.51
AnalystConsensusTarget US$47.33
AnalystLowTarget US$34.00
AnalystHighTarget US$55.00

OMCL Community Narratives

AnalystConsensusTarget·
Fair Value US$47.33 22.9% undervalued intrinsic discount

OmniSphere Adoption Will Simplify Healthcare Medication Management

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystLowTarget·
Fair Value US$34 7.4% overvalued intrinsic discount

Government Cost Containment And Cybersecurity Burdens Will Impair Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value US$55 33.6% undervalued intrinsic discount

Aging Population And Digital Transformation Will Drive Medication Automation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

Updated Narratives

OMCL logo

OMCL: Share Repurchases And Executive Shifts Will Drive Future Upside

Fair Value: US$47.33 22.9% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OMCL logo

Government Cost Containment And Cybersecurity Burdens Will Impair Margins

Fair Value: US$34 7.4% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OMCL logo

Aging Population And Digital Transformation Will Drive Medication Automation

Fair Value: US$55 33.6% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with moderate growth potential.

0 Risks
3 Rewards

Omnicell, Inc. Key Details

US$1.2b

Revenue

US$661.7m

Cost of Revenue

US$516.0m

Gross Profit

US$496.1m

Other Expenses

US$19.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.44
43.82%
1.69%
13.7%
View Full Analysis

About OMCL

Founded
1992
Employees
3600
CEO
Randall Lipps
WebsiteView website
www.omnicell.com

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Recent OMCL News & Updates

Recent updates

No updates